Literature DB >> 10483747

Cytokine release during hypoxia reoxygenation by Kupffer cells in rats with obstructive jaundice.

K Okamura1, S Noshima, K Esato.   

Abstract

The release of cytokine by Kupffer cells during hypoxia/reoxygenation was studied in vitro in male Wistar rats with obstructive jaundice to investigate the kinetics of interleukin-8 (IL-8) release by Kupffer cells during hypoxia/reoxygenation, and to study the influence of endotoxin during the reoxygenation period. The rats were divided into two groups: one that underwent bile duct ligation (group OJ), and one that underwent a sham operation (group C). Kupffer cells were isolated by collagenase digestion and centrifugal elutriation. The cells were first subjected to hypoxia as 95% nitrogen, after which they were given reoxygenation as 95% oxygen. In addition, they were stimulated with lipopolysaccharide (LPS) 0, 1, and 10 ng/ml. In both groups, the levels of IL-8 became increased during the period of hypoxia/reoxygenation, and reoxygenation after hypoxia further intensified IL-8 production. During the period of hypoxia, the IL-8 levels in group OJ were significantly increased compared with those in group C. With the LPS challenge, there was no significant difference in IL-8 levels in either group. In conclusion, obstructive jaundice induces the activation of Kupffer cells, resulting in increased IL-8 production during hypoxia/reoxygenation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483747     DOI: 10.1007/BF02482317

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

Review 1.  Perioperative complications in obstructive jaundice: therapeutic considerations.

Authors:  J A Pain; C J Cahill; M E Bailey
Journal:  Br J Surg       Date:  1985-12       Impact factor: 6.939

2.  Ischemia-reperfusion injury: the role of Kupffer cells in the production of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family.

Authors:  N Hisama; Y Yamaguchi; N Miyanari; O Ichiguchi; M Goto; K Mori; M Ogawa
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

3.  Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice.

Authors:  T Diamond; S Dolan; R L Thompson; B J Rowlands
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

4.  Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines.

Authors:  N Mukaida; Y Mahe; K Matsushima
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

5.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Anoxia-hyperoxia induces monocyte-derived interleukin-8.

Authors:  A P Metinko; S L Kunkel; T J Standiford; R M Strieter
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages.

Authors:  W W Zhong; P A Burke; A T Hand; M J Walsh; L A Hughes; R A Forse
Journal:  Arch Surg       Date:  1993-02

8.  Postoperative immunological function and jaundice.

Authors:  M C Regan; R M Keane; D Little; D Bouchier-Hayes
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

9.  Cytokine-induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cells.

Authors:  E Mawet; Y Shiratori; Y Hikiba; H Takada; H Yoshida; K Okano; Y Komatsu; M Matsumura; Y Niwa; M Omata
Journal:  Hepatology       Date:  1996-02       Impact factor: 17.425

10.  Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates.

Authors:  D A Lepay; C F Nathan; R M Steinman; H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.